What's Phillip Roe's mailing address?
Phillip's mailing address filed with the SEC is C/O CHANGE HEALTHCARE INC., 424 CHURCH STREET, SUITE 1400, NASHVILLE, TN, 37219.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Insiders trading at Change Healthcare Inc
Over the last 17 years, insiders at Change Healthcare Inc have traded over $283,424 worth of Change Healthcare Inc stock and bought 254,000 units worth $3,318,950 . The most active insiders traders include Howard L Lance, Robert Zollars et Fredrik J Eliasson. On average, Change Healthcare Inc executives and independent directors trade stock every 339 days with the average trade being worth of $729,227. The most recent stock trade was executed by Kriten Joshi on 1 August 2022, trading 8,656 units of CHNG stock currently worth $237,953.
What does Change Healthcare Inc do?
Change Healthcare is a leading independent healthcare technology company, focused on insights, innovation and accelerating the transformation of the U.S. healthcare system through the power of the Change Healthcare Platform. The company provides data and analytics-driven solutions to improve clinical, financial, administrative, and patient engagement outcomes in the U.S. healthcare system.
What does Change Healthcare Inc's logo look like?
Change Healthcare Inc executives and stock owners
Change Healthcare Inc executives and other stock owners filed with the SEC include:
-
Neil E. de Crescenzo IV,
Pres, CEO & Director -
Roderick H. O'Reilly,
Exec. VP and Pres of Software & Analytics -
Fredrik J. Eliasson,
Exec. VP & CFO -
Kriten J. Joshi Ph.D.,
Exec. VP & Pres of Network Solutions -
Kriten Joshi Ph.D.,
Exec. VP & Pres of Network Solutions -
Thomas P. Laur,
Exec. VP & Pres of Technology Enabled Services -
Katherine Wojtecki,
VP of External Communications -
David Elliott,
Sr. Director, Investor Relations & Corp. Devel. -
Monica R. McCullough,
Chief Compliance & Ethics Officer -
Loretta A. Cecil,
Exec. VP & Gen. Counsel -
Evan Smith,
Sr. VP of Investor Relations -
Steven B. Martin,
Exec. VP of Enterprise Technology -
Dr. August Calhoun,
Exec. VP and Pres of Sales & Operations -
Nella Domenici,
Director -
Diana Mckenzie,
Director -
Kriten Joshi,
See Remarks -
Qinan Ji,
Chief Executive Officer -
Lawrence W. Leighton,
Director -
Dawei She,
Chief Financial Officer -
Xiang Dong Abax Lotus Ltd.A...,
-
Xiang Dong Abax Lotus Ltd.A...,
-
Phillip W. Roe,
Director -
Thomas Mcenery,
EVP & Chief Marketing Officer -
Linda Whitley Taylor,
EVP & Chief People Officer -
Fredrik J Eliasson,
EVP & CFO -
August Calhoun,
See Remarks -
Paul Rareshide,
SVP, Corporate Controller -
Steven B. Martin,
EVP, Enterprise Technology -
Alex P. Choy,
See Remarks -
Philip M Pead,
Director -
Howard L Lance,
Director -
Loretta A. Cecil,
EVP, General Counsel -
Bansi Nagji,
Director -
Crescenzo Neil E. De,
President & CEO -
Thomas Laur,
See Remarks -
Roderick H. O'reilly,
See Remarks -
Robert Zollars,
Director -
Corp Mckesson,
-
Cof Facility Llc Blackstone...,
-
Management Associates Vi L....,
-
Tracy Byers,
SVP and GM, Enterprise Imaging